Niki BioSolutions, Inc. (NIKI) Operating cash flow 2018–2025
Niki BioSolutions, Inc. (NIKI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.8MFY2025 · since FY2018: -$10.0M → -$1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.8M | -54.4% |
| FY2024 | -$1.2M | +84.6% |
| FY2023 | -$7.7M | +37.3% |
| FY2022 | -$12.3M | +15.9% |
| FY2021 | -$14.7M | +8.0% |
| FY2020 | -$15.9M | -19.0% |
| FY2019 | -$13.4M | -33.4% |
| FY2018 | -$10.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NIKI financial trends
NIKI RevenueNIKI Net incomeNIKI Net marginNIKI Gross profitNIKI Gross marginNIKI Operating incomeNIKI Operating marginNIKI Free cash flowNIKI Capital expendituresNIKI Return on equityNIKI Stock buybacksNIKI Dividends paidNIKI Total assetsNIKI Total liabilitiesNIKI Shareholders’ equityNIKI overview →